Introduction
Deleted in liver cancer 2 (DLC2) is a member of the family of deleted in liver cancer genes; it is also known as steroidogenic acute regulatory protein-related lipid transfer (START) domain-containing protein 13 . This gene encodes a protein containing 1,113 amino acids that shares 51% identity and 65% similarity with the amino acid sequence of DLC1 [1] . DLC2 has a sterile alpha domain, a START domain and a Rho GTPase-activating protein (RhoGAP) domain. An additional functional domain was identified in residues 322-329 as an ATP/GTPbinding site [1] .
DLC2 was first thought to be a tumor suppressor gene because it is located on chromosome 13q12.3, a region often deleted in hepatocellular carcinoma [2] [3] [4] [5] [6] [7] [8] [9] . In addition, DLC2 expression is reduced in 18% of human he-patocellular carcinoma samples [1] . DLC2 exhibited RhoGAP activity specific for RhoA, which may mediate stress fiber formation [1, 10, 11] . The increased expression of its RhoGAP domain inhibited the proliferation of breast cancer cells [10] and HepG2 cells [11] by inactivating RhoA. In addition, increased expression of its GAP domain inhibited the migration of HepG2 cells [1, 11] . However, one study showed that DLC2 deficiency did not increase the rate of spontaneous liver tumor formation or diethylnitrosamine-induced hepatocarcinogenesis [12] .
Activation of RhoA is involved in the initiation and maintenance of inflammatory and neuropathic pain [13, 14] . Intraperitoneal injection of the ROCK inhibitor Y27632 in mice produced an anti-nociceptive effect to noxious thermal stimuli and inflammatory agents, such as formalin and acetic acid [14, 15] . This was probably because RhoA and ROCK regulate glutamine and/or acetylcholine release from peripheral nerves [16] [17] [18] . Thus, the RhoA/ROCK pathway plays a role in neurotransmitter release from sensory nerves. RhoA is also critical for the regulation of actin cytoskeleton formation during many cellular events. The regulation of the cytoskeleton, especially in nervous tissues, is important for neurite outgrowth, axonal targeting and branching. Although DLC2 is thought to regulate RhoA, its role in actin cytoskeletal organization and in the development of nervous tissues and neuropathic pain is not clear.
In this study, we investigated nerve morphology in DLC2 -/-mice and their response to noxious thermal stimuli and inflammatory chemicals. We found that there was no significant difference in the structure of the cutaneous and sural nerves in DLC2 -/-mice compared to DLC2 +/+ mice under normal conditions. In addition, hyperalgesia to heat and inflammation in DLC2 -/-mice was associated with increased activity of RhoA and ERK1/2, the signaling molecules involved in hyperalgesia, in the dorsal horn of the spinal cord.
Animals and Methods

Animals
Male 9-11-week-old wild-type (DLC2 +/+ ) and DLC2-deficient (DLC2 -/-) mice were used. DLC2 -/-mice were backcrossed to C57BL/6N for 6 generations. For morphological assessment, DLC2 +/+ and DLC2 -/-mice (N7 backcross to C57BL/6N) were mated with Thy1-YFP mice, which had yellowish-green fluorescent protein (YFP) in the sensory and motor neurons (31) . All mice were maintained in a 12/12-hour light/dark cycle with food and water ad libitum. Animal experiments were carried out following the guidelines set forth by the Committee on the Use of Live Animals in Teaching and Research at The University of Hong Kong.
Reverse-Transcription PCR
For semi-quantitative reverse-transcription PCR (RT-PCR) analysis, total RNA was prepared from mouse tissues using TRI reagent. First-strand cDNA was synthesized from 1 g total RNA using SuperScript TM (Invitrogen) reverse transcriptase. DLC2 mRNA and GAPDH were amplified by the following primers: for the DLC2 gene, the forward primer 5 -TGTGCTGGCAGGGAC-GGC and the reverse primer 5 -TGCCAATGTGCTGTGACTTT-GCAG were used, and for GAPDH, the forward primer 5 -CAT-CACCATCTTCCAGGA and the reverse primer 5 -CAGATCCA-CGACGGACA were used. The annealing temperature of the PCR was 55 ° C with 25 cycles. After PCR, 10 l PCR reaction mixture was applied to electrophoresis. The gel was stained and exposed to UV to visualize the band and captured by Gel Doc XR (BioRad). The intensity of the expected band was quantified by ImageJ (NIH). The intensity of the bands in different lanes was normalized with level of GAPDH, which served as a loading control.
In situ Hybridization
A pair of specific primers for the amplification of DLC2 riboprobe (forward primer: 5 -GGTCTGCTCTATTCACA, and reverse primer: 5 -TGCAAAGTCACAGCACATTGGCA) was designed using the free online software Primer 3 based on the published sequence of DLC2 (NM_146258.1). PCR fragments of DLC2 were generated from mouse brain cDNA and cloned into the pBluescript II SK+ vector. One microgram purified linearized DNA plasmid served as a template for RNA probe synthesis by in vitro RNA transcription with DIG labeling. The antisense or sense RNA probes were synthesized with T7 or T3 RNA polymerase, respectively, in transcription buffer (400 m M Tris-HCL pH 8.0, 60 mM MgCl 2 , 100 m M dithiothreitol, 20 m M spermidine) and DIG RNA labeling mix (Genius). The chromogenic reaction was carried out using BM purple in AP buffer.
Hot Plate Test and Tail Flick Test
The animals were tested for their response to heat stimulus [19] . Mice were placed in the bottom of a 4 liter glass beaker, which was incubated in a water bath kept at 55 ° C, and the responsive time required for the mice to lick and lift their rear paws or jump was determined. The maximum time for heat stimulus was 30 s to avoid tissue damage of the footpad. For the tail flick test, the tail of the mice was immersed in water maintained at 52.5 ° C, and the time for the mice to flick their tail was recorded as withdrawal latency. The maximum time of heat stimulus was 30 s to avoid tissue damage of the tail.
Formalin Test
A volume of 20 l of 1% formalin solution was injected subcutaneously through a fine-gauge needle into the ventral surface of one hind paw. The time engaged in licking and biting of the hind paw was recorded in the first 10 min, and then between the 20-and 30-min time points. The first 10 min, or Phase I, measured the acute pain response to the chemical. The period between 20 and 30 min is the Phase II pain response to inflammation.
Abdominal Constriction Tests
Mice were injected intraperitoneally with 10 ml/kg of 0.6% acetic acid or 10 ml/kg of 12 mg/ml magnesium sulfate as control. They were then placed in an observation cage, and the numbers of abdominal constrictions within the first 5 min or within 30 min were recorded.
Open Field Test
Mice were placed in a 240 ! 240 mm transparent plastic box for assessment. A 100 ! 100 mm arena at the center of the box was marked. Movements were recorded by a video camera that was connected to a computer for tracking and recording. The data were analyzed with EthoVision (Noldus) software, which revealed the total time the mouse was in motion, total distance traveled, velocity, and time spent in the center arena or margin of the arena.
Porsolt Swim Test
A cylinder with a 100-mm diameter was filled with water to a depth of at least 100 mm. Day 1 was a training session. Mice were placed in the water-filled cylinder for 6 min. Testing sessions were performed on Day 2. Mice were placed in the water-filled cylinder for 6 min, and their movements were recorded by a video camera and analyzed by EthoVision (Noldus) software as described above.
Measurement of Nerve Conduction Velocity
The nerve conduction velocity (NCV) was measured in 9-11-week-old mice according to the protocol mentioned previously [20, 21] . Briefly, mice were anesthetized with ketamine (100 mg/kg)/xylazine (10 mg/kg), and the sciatic nerves were stimulated (5-10 V, 0.05 ms single square-wave pulses) proximally with platinum needle electrodes (Grass, Quincy, Mass., USA). Compound muscle action potentials were recorded from the ipsilateral foot between digits 2 and 3. Afterwards, the length of the sciatic nerve was measured. The first compound action potential from individual stimulation was used for the measurement of motor latency, while the second one was used for the measurement of sensory latency. NCV was calculated by the difference of latencies between stimulation sites [latency of M-wave (notch) -latency of M-wave (ankle)] over the length of the sciatic nerve [22] .
Protein Analysis Using Western Blotting
Lumbar 4-5 spinal cords were dissected from mice 5 min, 30 min or 1 day after the formalin injection into their footpads. Spinal cords were rinsed with ice-cold phosphate-buffered saline (PBS) and separated longitudinally through the anterior median fissure to the posterior median sulcus. The half of the spinal cord which received the injection of PBS or formalin was defined as the ipsilateral side, whereas the uninjected side was defined as the contralateral side. Each half of the spinal cord was lysed separately by sonication in lysis buffer (50 m M Tris HCl pH 7.4, 1% NP-40, 0.25% Na-deoxycholate, 150 m M NaCl, 1 m M PMSF), and 50 g of protein extract was subjected to 12% SDS-polyacrylamide gel electrophoresis (PAGE). The gel was transferred to a polyvinylidene difluoride membrane (Hybond-P; GE Healthcare). The membrane was blotted with anti-phosphorylated ERK (pERK; 1: 1,000; Cell Signaling), then rescreened with anti-total ERK (1: 1,000; Cell Signaling) and finally blotted with anti-GAPDH (1: 1,000; Abcam). Immunoreactivity was detected with enhanced chemiluminescence according to the procedure provide by GE Healthcare.
Rhotekin Binding Assay
Tissues were lysed by sonication in lysis buffer (50 m M Tris HCl pH 7.4, 1% NP-40, 0.25% Na-deoxycholate, 150 m M NaCl, 1 m M PMSF). Each sample was sonicated twice for 30 s. The lysates were spun at 13,000 rpm for 2 min at 4 ° C. The amount of protein was measured by BioRad protein assay. The lysates were diluted into 1 g/ l. The diluted lysates (500 l) were used for RhoA pull-down assay. Ten microliters of cleaned agarose beads (Glutathione Sepharose 4B; GE Healthcare) was added to each sample and incubated for 1 h at 4 ° C. The lysates were transferred to new tubes, and 50 g of GST-RBD (GST fusion protein containing RhoA-binding domain of Rhotekin) bead was added into each sample and incubated with shaking for 1 h at 4 ° C. The supernatant was removed and the beads were washed in washing buffer three times. Bound proteins were fractionated on 12% SDS/ PAGE and detected with polyclonal antibody for RhoA (1: 1,000; Santa Cruz Biotechnology). Total tissue lysate was also analyzed with anti-RhoA antibody as a loading control. The level of active RhoA was determined after normalization with the total RhoA present in the tissue lysates.
In vivo Quantification of the Cutaneous Nerve in Live Animals
The method of quantification of cutaneous nerves was according to the protocol mentioned previously [23] . Briefly, animals were anesthetized with ketamine (100 mg/kg)/xylazine (10 mg/ kg). Hair on a defined area of the leg was removed and cleaned by PBS. Three squares of 4 ! 4 mm were marked on both legs: midcalf, mid-thigh and one in between those two areas. The YFPpositive small cutaneous fibers were quantitated under a fluorescent stereomicroscope. The density of all primary and secondary YFP-positive nerve fibers in these areas of the legs was expressed as average number of YFP-positive fibers per 100 mm 2 (# fibers/100 mm). The observer was blinded to the genotype of the experimental animals. The images of YFP-positive nerve fibers were captured by a Leica DC500 camera attached to the fluorescence stereomicroscope and processed with Leica IM 50 software.
Histological and Immunocytochemical Analysis
Footpad skins of mice were harvested and embedded in OCT. The skin samples were sectioned at 60 m, mounted on poly-Llysine coated glass slides, and then dried on the drier at 37 ° C for 30 min. The sections were washed with 1 ! PBS for 5 min and post-fixed with 4% paraformaldehyde (PFA) for 5 min. After fixation, the sections were rinsed with 1 ! PBS for 5 min. The slides were mounted with FluorSave TM (Merck Ltd.) and coverslip. Five regions of the skin sections were chosen and the images of these five regions were taken by using a confocal microscope (Zeiss 510-Meta). The criteria of counting small free-ending nerves were as described by Lauria et al. [24] .
Lumbar 4-5 spinal cords were dissected from mice 5 min, 30 min or 1 day after they received the 1% formalin injection into their footpads. The spinal cords were fixed in 4% PFA for 2 h at room temperature and then perfused with 20% sucrose overnight at 4 ° C. The cryopreserved spinal cords were sectioned at 20 m using cryostat (CM3000; Leica) and then mounted on poly-L -lysine coated glass slides.
Spinal cord sections were submerged in 4% PFA for 20 min at room temperature and then washed three times in PBS for 5 min. Diluted primary antibodies (anti-pERK1/2, 1: 100; Cell Signaling) were applied and incubated at 4 ° C for 16-18 h. The sections were then washed three times with 1 ! PBS for 5 min. For pERK staining, diluted secondary antibodies (goat anti-rabbit) were applied to each section and incubated at room temperature in the dark for 60 min. After secondary antibody incubation, the slides were washed with 1 ! PBS for 5 min. The ABC complex was added to each section and incubated for 30 min at room temperature.
The slides were then washed with 1 ! PBS for 5 min. The sections were then incubated in daminobenzidine for 2 min and then rinsed in 1 ! PBS. After washing off the antibody, images were captured using a fluorescent microscope (Leica). The number of pERK-positive neurons in the superficial laminae (I-II) was measured according to the method mentioned in previous reports [25, 26] .
Morphometric Analysis of Sural Nerves
Sural nerves of DLC2 +/+ and DLC2 -/-mice were harvested and fixed in primary fixative overnight at 4 ° C. Then, the tissues were rinsed in 0.1 M PBS three times for 5 min. The tissues were postfixed in 1% osmium tetroxide for 2 h at 4 ° C. After post-fixation, the tissues were rinsed in 0.1 M PBS three times for 5 min. After washing, the tissues were dehydrated in ascending ethanol series. After dehydration, tissues were infiltrated with propylene oxide, and propylene oxide:Epon (50: 50) for 1 h. Tissues were transferred to 100% Epon on a rotator overnight, embedded in Epon and polymerized in 60 ° C for 72 h. The 1-m-thick transverse sections of nerves were cut using Ultracut (Reichert-Jung, Leica) mounted on TESPA-coated glass slides and counter-stained with toluidine blue. The photomicrographs of the sural nerves were taken at a magnification of 1,000 ! using a computer-assisted image analyzing system (SPOT). The fascicular area, Feret diameter, and myelinated fiber number and size were analyzed and measured by ImageJ (NIH).
Statistical Analysis
All data were expressed as means 8 SEM. Statistical analysis was performed by Student's t test, Mann-Whitney test or one-way ANOVA. p values of 0.05 were considered statistically significant.
Results
DLC2 mRNA Is Expressed in Brain, Spinal Cord and Sciatic Nerve Tissue
To analyze the role of DLC2 in the neural control of pain, gene expression in brain, spinal cord and peripheral nerve tissue was analyzed using semi-quantitative RT-PCR. As shown in figure 1 A, DLC2 mRNA was present in each tissue and, as expected, absent in the corresponding tissues from DLC2 -/-mice. Within the brain, DLC2 expression was high in the cortex, cerebellum, hippocampus, and brainstem and low in the midbrain and olfactory bulb. In situ hybridization confirmed that DLC2 mRNA is localized in neurons of DLC2 +/+ mice in the above-mentioned regions, and expression was not detected in these areas in DLC2
-/-mice ( fig. 1 B) .
Increased RhoA Activity in Nerve Tissues of DLC2-Deficient Mice
The role of DLC2 as a RhoGAP specific for RhoA was established using cell lines [11, 27] . However, this function has not been confirmed in animal tissues. Therefore, RhoA activity in the brain and the peripheral nerves of DLC2 +/+ and DLC2 -/-mice was assessed using the Rhotekin binding assay [11, 27] . Significant differences in RhoA activity were not found in the brain tissue of DLC2 +/+ and DLC2 -/-mice (n = 5) ( fig. 1 C-b) . Interestingly, RhoA activity was significantly increased in the peripheral nerves of DLC2 -/-mice compared to that of DLC2 +/+ mice ( fig. 1 C-d) .
DLC2-Deficient Mice Experience More Severe Hyperalgesia
Because RhoA has been implicated in pain sensation and the regions of the brain in which DLC2 was highly expressed have been linked to pain processing pathways [28] [29] [30] [31] [32] , we investigated whether DLC2 is involved in pain sensation. We compared the response of 9-11-weekold DLC2
+/+ and DLC2 -/-mice to noxious thermal stimuli and inflammatory chemical-induced pain. In the hot plate and tail flick tests, DLC2-deficient mice showed shorter paw and tail withdrawal latencies than the DLC2 +/+ mice, suggesting that the former were more sensitive to painful thermal stimuli ( fig. 2 a, b ).
An injection of 1% formalin to the right hind paw causes the mouse to lick and bite its paw and flinch its leg. Such behavioral responses occur within 10 min (Phase I) and within 20-30 min (Phase II) after the formalin injection. Phase I is also referred to as the acute phase, whereas Phase II is often referred to as inflammation-induced pain phase. During Phase I, the frequency of licking and flinching in DLC2 -/-mice was not different from that in DLC2 +/+ mice. However, DLC2 -/-mice showed a significantly more intense Phase II pain response than the DLC2 +/+ mice. These mice spent more time biting, licking or flinching their right hind paw ( fig. 2 d) . The enhanced response to inflammatory pain in the formalin-injected DLC2 -/-mice was not due to more severe inflammation, as both DLC2 -/-and DLC2 +/+ mice showed a similar degree of swelling in the right hind paw (data not shown). An intraperitoneal injection of acetic acid and magnesium sulfate produces acute inflammatory pain and acute non-inflammatory, prostaglandin-independent pain, respectively [33] . In response to the acetic acid injection, DLC2 -/-mice showed significantly more abdominal constriction than DLC2 +/+ mice ( fig. 2 e) . In contrast, injection of magnesium sulfate resulted in a similar response in the DLC2 -/-and DLC2 +/+ mice ( fig. 2 f) . 
DLC2-Deficient Mice Have Normal Locomotor Activity and Do Not Exhibit Anxiety or Depressive
Behaviors DLC2 expression was analyzed in the hippocampus and the zona incerta, which are involved in locomotor activity, anxiety, depressive-like behavior, and pain modulation. In addition, anxiety is one of the potential components of pain response [34] . Therefore, we examined DLC2 -/-mice to determine whether they have any abnormalities in locomotor function, anxiety, or depressive behavior.
In the open field test, which examines general exploratory and locomotor activity, no significant differences in the total duration of locomotor activity and total distance traveled within 1 h were observed between DLC2 -/-and DLC2 +/+ mice, suggesting that the loss of DLC2 expression did not affect habituation ( fig. 2 g, h) . In addition, no significant difference in the moving velocity was observed between the mice, suggesting that locomotor activity was not affected by DLC2-deficiency ( fig. 2 i) . Furthermore, no differences in the time spent in the center of the test field were observed, suggesting that each genotype had a normal level of anxiety ( fig. 2 j) . In the Porsolt swim test, which is designed to reveal depression-like behavior [33, 35] , DLC2 -/-mice behaved similar to DLC2 +/+ mice in terms of the amount of struggling time and the amount of time spent floating ( fig. 2 k) . An increase in the floating time is indicative of depression because mice stop trying to get out of the water.
DLC2-Deficient Mice Show Increased Sensory NCV, but the Sural Nerve Morphology Appears Normal
Sensory NCV (SNCV) and motor NCV (MNCV) in the sciatic nerve of 9-11-week-old DLC2 +/+ and DLC2
-/-mice were determined as described in the Animals and Methods section. The DLC2 -/-mice MNCV appeared normal ( fig. 2 l) ; however, the SNCV was increased compared to that of DLC2 +/+ mice ( fig. 2 m) . Because only the SNCV was affected in DLC2 -/-mice, the sensory nerve morphology (i.e. sural nerve) of the DLC2 +/+ and DLC2 -/-mice was examined ( fig. 3 a, b) . Semi-thin (1 m) sections of the sural nerve were prepared, and morphometric analysis of the myelinated fibers was performed because these fibers are likely to affect NCV. The results showed no difference in the fascicular area and minimum Feret diameter ( fig. 3 c, d ), the number and density of myelinated fibers ( fig. 3 e, f) , axon diameter ( fig. 3 g, h) , and thickness of myelin ( fig. 3 i) between DLC2
-/-and DLC2 +/+ mice. In addition, the area of unmyelinated fibers was not significantly different between DLC2
+/+ and DLC2 -/-mice ( fig. 3 j) . Taken together, these data suggest that the loss of DLC2 does not affect sural nerve morphology.
The Number of Cutaneous Nerve Fibers Is Not Different between DLC2
+/+ and DLC2 -/-Mice A transgene that labels nerve fibers with YFP [23] was introduced into DLC2 +/+ and DLC2 -/-mice to facilitate non-invasive visualization of cutaneous nerve fibers. Both small and large YFP-labeled fibers in the skin can be visualized under the fluorescent microscope ( fig. 3 k) . Large nerve fibers were found in the dermis parallel to the skin surface ( fig. 3 ki, red arrowhead) . The small fibers ( fig. 3 ki, white arrowhead) in the epidermal layer perpendicular to the skin surface were cutaneous nerves. The nerves that branched out from the large fibers were termed primary fibers ( fig. 3 kii, white arrowhead) , whereas those bifurcating from the primary fibers ( fig. 3 kiii, white arrow) were termed secondary fibers. Non-invasive microscopic visualization was unable to distinguish between myelinated and unmyelinated fibers.
We quantified the cutaneous nerve fiber density in three regions of the thigh in 9-11-week-old DLC2 +/+ YFP and DLC2 -/-YFP mice [23] . As shown in figure 3 l, there was no significant difference in the primary and secondary cutaneous nerve fibers between DLC2 +/+ and DLC2
-/-mice. The cutaneous nerve fiber density within the epidermis and perpendicular to the dermis in five regions of the footpad skin was also examined and also showed no difference between DLC2 +/+ and DLC2 -/-mice ( fig. 3 m, n) .
RhoA Activity in the Spinal Cord of DLC2-Deficient Mice Is Increased 30 Min after a Formalin Injection
To determine whether RhoA was involved in the Phase II hyperalgesia response in DLC2 -/-mice, RhoA activity in the spinal cord 30 min after the formalin injection was determined. In DLC2 +/+ mice, the RhoA activity was not different between the ipsilateral (same side as formalin injection) and contralateral (opposite side of formalin injection) side of the L1-S1 spinal cord ( fig. 4 ) . In DLC2 -/-mice, a significant increase in RhoA activity was observed in the ipsilateral side of the spinal cord compared to the contralateral side ( fig. 4 b) .
The Number of pERK1/2-Positive Cells in the Spinal Dorsal Horn Is Increased
Phosphorylation of ERK in the spinal dorsal horn is thought to play an important role in the inflammatory pain response [36] . To determine whether ERK1/2 is involved in hyperalgesia in DLC2 -/-mice, spinal cords were dissected 5 and 30 min after a formalin injection and were stained with antibodies against pERK1/2.
In naïve DLC2 +/+ and DLC2 -/-mice, the number of pERK1/2-positive cells in the superficial layer of the spinal dorsal horn was not significantly different ( fig. 5 a) . The number of pERK1/2-positive cells in the ipsilateral dorsal horn of DLC2 +/+ mice was significantly increased 5 min after the injection in comparison to the contralateral side ( fig. 5 ai, aii) . The number of pERK1/2-positive cells in the ipsilateral side of DLC2 -/-mice was also significantly higher in comparison to the contralateral side ( fig. 5 aiii,  aiv) ; however, the degree of the increase was much higher than that in DLC2 +/+ mice ( fig. 5 ai, aiii, di) . At 30 min after the formalin injection, the number of pERK1/2-positive cells in the superficial spinal dorsal horn was reduced in both the contralateral and ipsilateral sides in DLC2 +/+ and DLC2 -/-mice ( fig. 5 c, dii) , and no significant difference in the number of pERK1/2-positive cells was observed.
Western blot analysis confirmed that the pERK1/2 level in the ipsilateral spinal cord of DLC2 -/-mice was significantly higher than that of DLC2 +/+ mice ( fig. 5 diii,  div) . However, the difference in pERK1/2 expression between the contralateral and ipsilateral spinal cord of DLC2 +/+ mice and the difference of pERK1/2 expression between the contralateral and ipsilateral spinal cord of DLC2 -/-mice was not observed in the quantitative Western blot histogram.
Discussion
Loss of DLC2 Does Not Affect Locomotor Activity, Anxiety, and Depression
In this report, we showed that DLC2-null mice were more sensitive to noxious thermal stimuli and chemically induced inflammatory pain. DLC2 is a newly identified RhoGAP specific for RhoA [1, 11] . Several RhoGAPs are thought to be involved in neuronal morphogenesis. Oligophrenin-1 appears to play a role in neurite outgrowth and the regulation of synaptic connectivity [37] . p250GAP, which is a RhoGAP for RhoA and Cdc42, is enriched in the NMDA receptor complex and regulates dendritic spine structure in an NMDA receptor-dependent manner [38] . DLC1 is also a RhoGAP specific for RhoA and Cdc42 [39] and is thought to be involved in neural tube development. DLC1-null mice die in utero due to defects in neural tube development [40] . One of the RhoGAPs, p190GAP, is involved in axon guidance and fasciculation [41] . Interestingly, DLC2-null mice appeared normal with no obvious abnormality in the nervous tissues. Their locomotor activity appeared normal, without exhibiting any signs of anxiety-like or depression-like behavior in the open field test and Porsolt swim test, respectively. The morphology of the cutaneous nerves, such as the sural nerve, appeared normal. Interestingly, DLC2 -/-mice were more sensitive to noxious thermal stimuli and inflammatory pain than DLC2 +/+ mice. A hyperalgesic response to noxious thermal stimuli was observed in the hot plate and tail flick tests. In addition, a hyperalgesic response to inflammatory pain was determined by quantifying the Phase II response during a formalin test. The abdominal constriction response to an inflammatory agent was also determined. DLC2 -/-mice were hypersensitive to acetic acid-induced (inflammatory) pain, whereas they exhibited a normal response to magnesium sulfate-induced (non-inflammatory acute) pain. Hyperalgesia to inflammatory pain in DLC2 -/-mice was not due to increased inflammation in the injected footpads, as the swelling of the injected footpads was not significantly different from that of the DLC2 +/+ mice (data not shown). Taken together, these observations indicate that DLC2 is involved in the modulation of pain sensation. DLC2 expression was present in several regions of the brain that are involved in pain modulation, including the hippocampus CA1 region [31] , dentate gyrus [42] , and zona incerta [43] .
More Severe Hyperalgesia Is Observed in DLC2-Deficient Mice
SNCV Is Increased in DLC2
-/-Mice DLC2 -/-mice showed a normal MNCV, although the SNCV was increased compared to that of DLC2 +/+ mice. The SNCV measured in this study was the conduction velocity of a H-reflex, which runs from the sensory nerves to the spinal cord and back to the motor nerves [44] . A faster SNCV may thus contribute to a shorter withdrawal latency in the hot plate test and the tail flick test. Increased RhoA activity in the peripheral nerves of DLC2 -/-mice may also contribute to the hypersensitivity to thermal stimuli, as the activation of RhoA and ROCK induce neurotransmitter release through a reorganization of the actin cytoskeleton [14] .
The increased SNCV in DLC2 -/-mice was not associated with a noticeable change in the structure of the sural nerves. The fascicular area, the number of myelinated fibers and the axon diameter were similar in both the DLC2 +/+ and DLC2 -/-mice. Unfortunately, the resolution of the sural nerve semi-thin sections was not sufficient to reveal the morphology of the unmyelinated fibers. The area of the unmyelinated fibers in the sural nerves was determined by deducing the fascicular area by the area of the myelinated fibers. The area of the unmyelinated fibers in the sural sections was not significantly different between DLC2 +/+ and DLC2 -/-mice. Our data suggest that DLC2 -/-mice have normal sural nerve morphology and myelination.
In addition to the nerve structure, the post-synaptic release of nitrite oxide (NO) and its subsequent diffusion play an important role in synaptic plasticity and longterm potentiation [45] . ROCK regulates NO release through the stimulation of prostaglandin E2 [46] . Determining NADPH-diaphorase and nNOS activity in DLC2 -/-mice would shed light on the role of RhoA in NCV. Moreover, RhoA activation induces the release of neurotransmitters such as glutamate through the reorganization of the actin cytoskeleton at the cell periphery by activating ROCK and myristoylated alanine-rich C-kinase substrate (MARCKS) [17] . The increase in pre-synaptic RhoA activity also induced acetylcholine release in Caenorhabditis elegans through an unknown mechanism [18] . Therefore, increased SNCV in DLC2 -/-mice may be the result of altered synaptic connectivity and function, although further studies are required to support this hypothesis.
RhoA Activity Is Increased in the Spinal Cord of DLC2
-/-Mice after a Formalin Injection The injection of formalin into the rodent hind paw produces two distinct phases of nociceptive behavior. These two pain phases involve different physiological mechanisms. The Phase I pain response occurs during the chemical activation of primary afferent nociceptors at the injection sites, whereas the Phase II pain response is the result of factors released from local inflammation at the injection site. In this study, the DLC2 -/-mice displayed a hyperalgesic Phase II response after the formalin injection, indicating that DLC2 may modulate inflammatory pain. This phenotype was confirmed by the acetic acid abdominal contraction test ( fig. 2 e) , which is another inflammatory pain test.
Hyperalgesia induced by inflammatory pain in DLC2 -/-mice may involve RhoA. A dramatic increase in RhoA activity was observed in the ipsilateral spinal cord 30 min after the formalin injection. It is well known that the activation of RhoA and its effector ROCK is related to spinal nociceptive transmission [14, 15, 47, 48] and that the inhibition of ROCK attenuates inflammatory and neuropathic pain [13, 47] . In addition, a recent paper showed that the RhoA/ROCK pathway is also involved in thermal hyperalgesia in diabetic mice [49] . Furthermore, the activation of RhoA and ROCK is related to spinal nociceptive transmission [14, 15, 47, 48] , and the inhibition of ROCK attenuates inflammatory and neuropathic pain [13, 47] , whereas the activation of RhoA by the injection of lysophosphatidic acid induces hyperalgesia and allodynia [13] . The injection of H-1152, a ROCK inhibitor, significantly reduced the Phase II pain behavior resulting from the formalin injection by attenuating the phosphorylation of MARCKS in the superficial dorsal horn of the spinal cord [14] . Therefore, RhoA and ROCK are important regulators of inflammatory pain, and the de-regulation of RhoA may influence the inflammatory pain response.
The in vivo function of the DLC2 RhoGAP domain has not been fully determined, although this domain has been shown to have RhoGAP activity for RhoA and CDC42 in vitro [1] . However, the overexpression of DLC2 resulted in the inhibition of RhoA activity and in the reduction of actin stress fiber formation [11, 50] , suggesting that DLC2 predominately regulates RhoA. Therefore, DLC2 is a negative regulator of RhoA activity, which may be involved in pain modulation.
ERK1/2 Signaling May Affect DLC2-Induced
Hyperalgesia ERK1/2 activation is involved in the inflammatory pain response but does not affect basal pain sensitivity [26] . Increased ERK1/2 activation was detected after complete Freund's adjuvant-induced inflammatory pain [26] . In addition, the inhibition of pERK1/2 attenuates inflammatory [25, 36, 51] , heat, and mechanical pain hypersensitivity [26] . In this study, we observed an increase in the number of pERK1/2-positive cells in the ipsilateral dorsal horn of the spinal cord (L4 and L5) of DLC2 -/-mice 5 min after a formalin injection, which is similar to a previous report [25] . The activity of ERK1/2 in both sides of the spinal cord was increased in DLC2 -/-mice compared to DLC2 +/+ mice. In contrast to the immunocytochemical data, the quantitative Western blot analysis did not show an increase in pERK1/2 in the ipsilateral spinal cord compared to the contralateral side in DLC2 +/+ mice 5 min after a formalin injection. Western blot analysis showed that pERK1/2 was increased in both the contralateral and ipsilateral sides of the spinal cord in DLC2 -/-mice compared to DLC2 +/+ mice 5 min after a formalin injection. Nevertheless, an increase in pERK1/2 in the ipsilateral dorsal horn of the spinal cord in DLC2 -/-mice was observed 5 min after a formalin injection compared to DLC2 +/+ mice.
The activation of ERK1/2 peaks 5 min after stimulation and then decays 30-60 min after stimulation [25, 26, 52] . It is not yet clear whether ERK1/2 activation occurs 5 min after a formalin injection, but the hyperalgesic effects were observed during Phase II, 20-30 min after the injection. Some studies suggest that ERK1/2 is involved in the central sensitization to acute noxious stimuli [26] and increased excitability of spinal neurons through the phosphorylation of the A-type potassium channel Kv4.2 [53] . In addition, ERK1/2 induces transcriptional changes in the spinal cord. pERK1/2 translocates to the nucleus and phosphorylates the transcription factor cAMP element-binding protein (CREB) and induces transcription via CREB kinase [54] [55] [56] . Moreover, the activation of ERK has been shown to induce NK-1, which plays an important role in inflammatory pain hypersensitivity [57, 58] , and the expression of prodynorphin, which is involved in inflammation-induced enhanced excitability and expanded dorsal horn neuronal receptive fields [59, 60] after the induction of inflammatory pain [26] . Therefore, activation of ERK may contribute to acute inflammatory hyperalgesia through post-translational and -transcriptional regulation.
Recently, increasing evidence has suggested that RhoA regulates ERK1/2 signaling directly or through the regulation of MEK [61] [62] [63] , although evidence for a direct link between RhoA and ERK1/2 activation in nervous tissues has not yet been determined. In this study, ERK1/2 activity in the ipsilateral spinal cord of DLC2 -/-mice peaked 5 min after the formalin injection, whereas RhoA in the ipsilateral spinal cord of DLC2 -/-mice was significantly activated 30 min after the injection, i.e. after Phase II. These data suggest that the induction of pERK1/2 in DLC2 -/-mice during inflammatory pain may be independent of RhoA activation. A recent study showed that DLC2 altered ERK1/2 activity and cell growth in HepG2 cells through the Raf1-ERK1/2-p70S6K pathway [27] , suggesting that further investigation is necessary to reveal the underlying mechanism involving DLC2, RhoA, and ERK1/2 in pain perception.
Taken together, we have shown that DLC2 has RhoGAP activity for RhoA in nervous tissue. Loss of DLC2 led to the activation of RhoA and hyperalgesia after painful stimuli, such as formalin injection. Concomitantly, increased ERK1/2 phosphorylation was also observed in the ipsilateral side of the spinal cord of DLC2 -/-mice after injecting the animals with the inflammatory agent formalin ( fig. 6 ). ERK activation also induced hypersensitivity to pain through the upregulation of various downstream effectors and an increase in neuronal excitability in the spinal cord [53] . Furthermore, ROCK activation downstream of RhoA may also contribute to hypersensitivity to pain by the phosphorylation of MARCKS and increased glutamate release. However, the precise mechanism involving DLC2, RhoA, and ERK1/2 has not yet been identified. Therefore, further investigation is necessary to determine the detailed mechanism of DLC2 involvement in inflammatory pain. 
